Ruyi Guo

Quanzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Epidemiology, transmission, vector and factors analysis of chikungunya outbreak in 2025, Quanzhou City of China.

Epidemiology, transmission, vector and factors analysis of chikungunya outbreak in 2025, Quanzhou City of China.

Journal: Frontiers in public health
Published: May 30, 2026

A Local Chikungunya Fever Outbreak Field Investigation - Fujian Province, China, 2025.

A Local Chikungunya Fever Outbreak Field Investigation - Fujian Province, China, 2025.

Journal: China CDC weekly
Published: December 23, 2025

The lignan compound matairesinol monoglucoside induces type I interferon production in HBV infection immunity by regulating STING signaling.

The lignan compound matairesinol monoglucoside induces type I interferon production in HBV infection immunity by regulating STING signaling.

Journal: RSC medicinal chemistry
Published: May 23, 2025

IL2-inducible T-cell Kinase is Required for HBV-induced Type T Interferon Expression and Antiviral Response.

IL2-inducible T-cell Kinase is Required for HBV-induced Type T Interferon Expression and Antiviral Response.

Journal: Journal of clinical and translational hepatology
Published: June 18, 2022

3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy.

3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy.

Journal: Anti-cancer drugs
Published: January 04, 2021

Manganese Breaks the Immune Tolerance of HBs-Ag.

Manganese Breaks the Immune Tolerance of HBs-Ag.

Journal: Open forum infectious diseases
Published: July 29, 2020

Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance.

Combination leflunomide and methotrexate impedes the recovery of liver fibrosis, partly through inhibition of myeloid cell admittance.

Journal: Molecular medicine reports
Published: March 19, 2018

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker.

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker.

Journal: OncoTargets and therapy
Published: March 06, 2018

Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure.

Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure.

Journal: Medicine
Published: April 22, 2016

Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis

Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: May 29, 2015

Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.

Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.

Journal: Viral immunology
Published: February 25, 2015

The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.

The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.

Journal: Clinical and vaccine immunology : CVI
Published: October 07, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026